Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

190
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
190

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.

JCO precision oncology·2026
Same author

Clinical and genomic predictors of sipuleucel-T outcomes in men with metastatic androgen pathway modulator resistant prostate cancer.

Research square·2026
Same author

Reply to: PCWG4: A Missed Opportunity to Make Bone-Protective Agents Mandatory for Patients With Bone Metastatic Castration-Resistant Prostate Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

JCO precision oncology·2026
Same author

Germline CDK12 variants in aggressive prostate cancer.

Cancer discovery·2026
Same author

Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.

Journal for immunotherapy of cancer·2026

相关实验视频

Updated: Feb 27, 2026

Establishment and Maintenance of Patient-derived Prostate Cancer Organoids: A Detailed Experimental Protocol
09:04

Establishment and Maintenance of Patient-derived Prostate Cancer Organoids: A Detailed Experimental Protocol

Published on: November 14, 2025

529

前列腺癌患者的试验设计和目标:前列腺癌工作组4的建议.

Andrew J Armstrong1, Michael J Morris2, Wassim Abida2

  • 1Department of Medicine, Duke Cancer Institute Center for Prostate and Urologic Cancer, Duke University, Durham, NC.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology
|February 26, 2026
PubMed
概括

提供了晚期前列腺癌临床试验的最新标准,重点关注新术语,成像和患者分层. 这些指导方针旨在优化不同患者群体的治疗效益.

更多相关视频

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

930

相关实验视频

Last Updated: Feb 27, 2026

Establishment and Maintenance of Patient-derived Prostate Cancer Organoids: A Detailed Experimental Protocol
09:04

Establishment and Maintenance of Patient-derived Prostate Cancer Organoids: A Detailed Experimental Protocol

Published on: November 14, 2025

529
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

17.2K
A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

930

科学领域:

  • 在瘤学瘤学.
  • 临床试验设计 临床试验设计
  • 前列腺癌研究 研究前列腺癌

背景情况:

  • 先进的前列腺癌研究需要更新的术语和临床试验的最佳实践.
  • 新的成像方式,分子表型和疗法需要修订试验行为标准.

研究的目的:

  • 根据新出现的证据,制定高级前列腺癌临床试验的最新标准.
  • 在生物标志物背景下提供关于试验设计,资格和终点评估的指导.

主要方法:

  • 召集了一个国际专家委员会,前列腺癌工作组4 (PCWG4),从2016-2025.
  • 根据新出现的证据和临床试验数据制定了更新的标准.

主要成果:

  • 重新定义疾病状态术语,重点关注雄激素通路调节和以患者为中心的背景.
  • 建立了新的推资格,响应终点,成像 (包括PET定义的疾病) 和患者报告的结果.
  • 强调需要验证成像和分子标准来进行风险分层和结果评估.

结论:

  • PCWG4为患者和瘤特征,治疗开发和成像标准提供了最新的建议.
  • 指导范围扩展到早期疾病状态,以适应不断变化和异质的患者群体.
  • 目标是优化所有晚期前列腺癌患者的治疗效益.